![]() |
Valoración de DCF de Eyenovia, Inc. (Eyen)
US | Healthcare | Biotechnology | NASDAQ
|

- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Eyenovia, Inc. (EYEN) Bundle
¡Agilice su análisis y mejore la precisión con nuestra calculadora DCF (Eyen)! Con datos auténticos de EyeNovia y supuestos personalizables, esta herramienta le permite pronosticar, evaluar y valorar Eyenovia, Inc. como un inversor experto.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | 2.0 | 14.0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 0 | 600 | -100 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA | -21.3 | -19.7 | -12.2 | -26.6 | -24.1 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | 100 | -982.87 | -86.92 | 100 | -636547.03 | -17.38 | -17.38 | -17.38 | -17.38 | -17.38 |
Depreciation | .0 | .1 | .2 | .3 | .8 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 100 | 4.77 | 1.58 | 100 | 20681.49 | 61.27 | 61.27 | 61.27 | 61.27 | 61.27 |
EBIT | -21.3 | -19.8 | -12.4 | -26.9 | -24.9 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | 100 | -987.64 | -88.5 | 100 | -657228.52 | -17.7 | -17.7 | -17.7 | -17.7 | -17.7 |
Total Cash | 14.2 | 28.4 | 19.5 | 22.9 | 14.8 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .4 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .1 | 3.1 | 2.1 | 1.8 | .6 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 100 | 155.9 | 15.35 | 100 | 16491.07 | 83.07 | 83.07 | 83.07 | 83.07 | 83.07 |
Inventories | -.1 | 1.6 | .0 | 3.6 | .1 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 100 | 80 | 0 | 100 | 2899.34 | 76 | 76 | 76 | 76 | 76 |
Accounts Payable | 1.5 | 1.5 | 1.6 | 1.4 | 1.8 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 100 | 73.08 | 11.53 | 100 | 46294.48 | 76.92 | 76.92 | 76.92 | 76.92 | 76.92 |
Capital Expenditure | -.2 | -.3 | -1.6 | -.9 | -4.0 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 100 | -13.06 | -11.56 | 100 | -104846.5 | -24.92 | -24.92 | -24.92 | -24.92 | -24.92 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -21.1 | -19.7 | -12.6 | -26.6 | -24.9 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -19.8 | -24.6 | -11.3 | -30.7 | -23.1 | -1.0 | .0 | .0 | .0 | .0 |
WACC, % | 10.82 | 10.83 | 10.84 | 10.81 | 10.84 | 10.83 | 10.83 | 10.83 | 10.83 | 10.83 |
PV UFCF | ||||||||||
SUM PV UFCF | -.9 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | -1 | |||||||||
Net Debt | 1 | |||||||||
Equity Value | -2 | |||||||||
Diluted Shares Outstanding, MM | 41 | |||||||||
Equity Value Per Share | -0.05 |
What You Will Get
- Real Eyenovia Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Eyenovia, Inc. (EYEN).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specifically for Eyenovia, Inc. (EYEN).
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Eyenovia, Inc. (EYEN)’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for Eyenovia, Inc. (EYEN).
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Eyenovia, Inc. (EYEN).
Key Features
- Comprehensive EYEN Data: Pre-loaded with Eyenovia's historical performance metrics and future growth forecasts.
- Customizable Financial Inputs: Tailor revenue projections, profit margins, discount rates, tax implications, and capital investment assumptions.
- Interactive Valuation Framework: Instant recalculations of Net Present Value (NPV) and intrinsic value based on your customized parameters.
- Multiple Scenario Analysis: Develop various forecasting scenarios to explore different valuation possibilities.
- Intuitive User Interface: Designed to be accessible for both industry professionals and newcomers.
How It Works
- 1. Open the Template: Download and open the Excel file featuring Eyenovia, Inc. (EYEN) preloaded data.
- 2. Edit Assumptions: Modify essential inputs such as growth rates, WACC, and capital expenditures for Eyenovia, Inc. (EYEN).
- 3. View Results Instantly: The DCF model automatically computes intrinsic value and NPV for Eyenovia, Inc. (EYEN).
- 4. Test Scenarios: Evaluate various forecasts to explore different valuation results for Eyenovia, Inc. (EYEN).
- 5. Use with Confidence: Deliver professional valuation insights to enhance your decision-making regarding Eyenovia, Inc. (EYEN).
Why Choose This Calculator for Eyenovia, Inc. (EYEN)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters to suit your specific analysis needs.
- Real-Time Feedback: Observe immediate changes in Eyenovia’s valuation as you modify inputs.
- Preloaded Data: Comes with Eyenovia’s current financial information for swift evaluations.
- Relied Upon by Experts: Employed by investors and analysts for making strategic decisions.
Who Should Use This Product?
- Individual Investors: Gain insights to make informed decisions regarding Eyenovia, Inc. (EYEN) stock transactions.
- Financial Analysts: Enhance valuation assessments with comprehensive financial models tailored for Eyenovia, Inc. (EYEN).
- Consultants: Provide clients with accurate and timely valuation analyses related to Eyenovia, Inc. (EYEN).
- Business Owners: Learn from Eyenovia, Inc. (EYEN) to understand valuation metrics that can influence your own business strategies.
- Finance Students: Explore real-world valuation methods using data and case studies from Eyenovia, Inc. (EYEN).
What the Template Contains
- Pre-Filled DCF Model: Eyenovia’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Eyenovia’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.